Raymedica Hires New Vice President of Sales & Marketing and Vice President of R&D/Operations

MINNEAPOLIS, May 3 - Raymedica, Inc., a medical device developer and manufacturer, announced today that Jon R. Luedke has joined Raymedica as Vice President of Sales & Marketing and Steven J. Seme as Vice President of R&D/Operations.

John J. Viscogliosi, Chairman and CEO, "In order to achieve the goals Raymedica is striving for, it's necessary to have experienced leaders with strong spine industry backgrounds join the team. Jon Luedke joins Raymedica with over 19 years of senior management, sales, marketing, and medical industry experience. Steven Seme provides us with beneficial product development leadership and operations expertise. Both Jon and Steven have a strong background in emerging technologies and relationships with key opinion leaders in the spine area. I am very pleased to welcome Jon and Steven to our executive team. They bring a wealth of experience and knowledge to an already talented group."

Prior to joining Raymedica Jon Luedke directed Zimmer Spine's OrthoBiologic Business unit managing the areas of business planning, strategy development, and new product planning, sales and distribution. Mr. Luedke has also served in various executive positions within Fortune 500 companies and start-up companies where he was responsible for all marketing, strategic development, and financial activities.

Steven Seme has over 10 years of extensive implantable medical device experience. His knowledge spans the technical, operational and leadership side of both start-up and large global companies in the areas of diagnostic, orthopedic and spine. Most recently, Mr. Seme directed, from product concept to market release, several spinal device projects and key business development teams as Director of Product Development at Zimmer Spine.
"I look forward to making significant contributions to Raymedica, especially the execution of the strategic sales & marketing plan," said Jon Luedke. "The company's vision to be the leader in non-fusion technology is highly achievable with the growing need for this technology." Steven Seme adds, "Joining a company that is not only the first to market, but the pioneer of the nucleus replacement market and possesses a strong patent portfolio makes Raymedica a company with unlimited potential."

About Raymedica, Inc.
Raymedica develops, manufactures and markets medical device systems designed to treat patients with degenerative disc disease that have not responded to non-surgical treatment. Raymedica pioneered and is the scientific, clinical and regulatory leader in the nucleus replacement segment of the non-fusion spine market. Raymedica devices have been used in more than 3,400 procedures globally. Raymedica's products are currently available worldwide, but are limited to investigational use only in the United States. For more information, visit the Company's website at http://www.raymedica.com .